Crucumin Effects on the Immune System in Osteoarthritis Patients
NCT ID: NCT03715140
Last Updated: 2020-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
30 participants
INTERVENTIONAL
2019-05-01
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation Effect of Crocina on The Cellular Immune Responses in Osteoarthritis Patients
NCT03375814
Effect of Astaxanthin in Moderate to Severe Knee Osteoarthritis
NCT05437601
Efficacy Test of Curcuminoid Standardized Turmeric Capsules to Improving Inflammatory Biomarkers in Osteoarthritis Genu
NCT07183215
Effectiveness of Curcumin-based Food Supplement in Reducing Pain and Inflammatory Component in Osteoarthritis
NCT04207021
Exploratory Non Comparative Study to Evaluate the Efficacy of Highly Bioavailable Curcumin (Flexofytol) in Patients With Knee Osteoarthritis
NCT01909037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients who will recieve crucumin
patients who prescribing crucumin 80 mg daily for three months will be evaluated. A sample will be taken before taking the drug.
Crucumin
Evaluation of the effect of Crucumin in patients with osteoarthritis
Patients who will receive placebo
Patients who prescribing placebo daily for three months will be evaluated. A sample will be taken before taking the placebo.
Placebo
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Crucumin
Evaluation of the effect of Crucumin in patients with osteoarthritis
Placebo
Placebo
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mashhad University of Medical Sciences
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Mojgan Mohammadi
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mojgan Mohammadi, Ph.D
Role: PRINCIPAL_INVESTIGATOR
Department of Immunology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mahdi Atabaki
Mashhad, , Iran
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IR.MUMS.MEDICAL.REC.1397.118
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.